BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Sep 5, 2025; 16(3): 109046
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.109046
Figure 3
Figure 3 Predicted neurotransmitter-related metabolic pathways analyzed by Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2, compared between healthy controls and irritable bowel syndrome with predominant constipation responders to electroacupuncture, indicating potential microbiome shifts associated with therapeutic response. ACP: Irritable bowel syndrome patients after electroacupuncture; ACP1M: Irritable bowel syndrome patients after electroacupuncture and one-month follow-up; IBS: Irritable bowel syndrome patients.